BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 6430722)

  • 1. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of hCG administration in cycles stimulated for in vitro fertilization: specific impact of heterogeneous follicle sizes and steroid concentrations in plasma and follicle fluid on decision procedures.
    Inaudi P; Germond M; Senn A; De Grandi P
    Gynecol Endocrinol; 1995 Sep; 9(3):201-8. PubMed ID: 8540289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II, 1981.
    Garcia JE; Jones GS; Acosta AA; Wright G
    Fertil Steril; 1983 Feb; 39(2):174-9. PubMed ID: 6401635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The day of initiation of human menopausal gonadotropin stimulation affects follicular growth in in vitro fertilization cycles.
    Dlugi AM; Laufer N; Decherney AH; Polan ML; Haseltine FP; Tarlatzis BC; Graebe RA; Barnea ER; Naftolin F
    J In Vitro Fert Embryo Transf; 1985 Mar; 2(1):33-40. PubMed ID: 3926922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human menopausal gonadotropin/human chorionic gonadotropin follicular maturation for oocyte aspiration: phase I, 1981.
    Garcia JE; Jones GS; Acosta AA; Wright G
    Fertil Steril; 1983 Feb; 39(2):167-73. PubMed ID: 6217993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered follicular development in clomiphene citrate versus human menopausal gonadotropin-stimulated cycles for in vitro fertilization.
    Dlugi AM; Laufer N; Botero-Ruiz W; DeCherney AH; Polan ML; Haseltine FP; Mezer HC; Behrman HR
    Fertil Steril; 1985 Jan; 43(1):40-7. PubMed ID: 3155509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial.
    Mochtar MH; Hogerzeil HV; Mol BW
    Hum Reprod; 1996 Aug; 11(8):1602-5. PubMed ID: 8921100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential use of clomiphene citrate, human menopausal gonadotropin, and human chorionic gonadotropin in human in vitro fertilization. II. Study of luteal phase adequacy following aspiration of the preovulatory follicles.
    Cohen JJ; Debache C; Pigeau F; Mandelbaum J; Plachot M; de Brux J
    Fertil Steril; 1984 Sep; 42(3):360-5. PubMed ID: 6432585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The empty follicle syndrome: a pharmaceutical industry syndrome.
    Zegers-Hochschild F; Fernández E; Mackenna A; Fabres C; Altieri E; Lopez T
    Hum Reprod; 1995 Sep; 10(9):2262-5. PubMed ID: 8530648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between preovulatory serum 17 beta-estradiol pattern and conception in human menopausal gonadotropin-human chorionic gonadotropin stimulation.
    Laufer N; DeCherney AH; Tarlatzis BC; Naftolin F
    Fertil Steril; 1986 Jul; 46(1):73-6. PubMed ID: 3087791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulating the follicular phase in IVF cycles: a comparison of two hMG stimulation protocols.
    Rabinowitz R; Simon A; Lewin A; Bar-Hava I; Schenker JG; Laufer N
    Gynecol Endocrinol; 1989 Jun; 3(2):117-23. PubMed ID: 2510460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of hCG versus GnRH analog for releasing oocytes following ultra low-dose gonadotropin stimulation.
    Check JH; Vetter BH; Weiss W
    Gynecol Endocrinol; 1993 Jun; 7(2):115-22. PubMed ID: 8213225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.
    Araujo E; Bernardini L; Frederick JL; Asch RH; Balmaceda JP
    J Assist Reprod Genet; 1994 Feb; 11(2):74-8. PubMed ID: 7819706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization.
    Muasher SJ; Garcia JE; Rosenwaks Z
    Fertil Steril; 1985 Jul; 44(1):62-9. PubMed ID: 3924669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular maturation parameters associated with the failure of oocyte retrieval, fertilization, and cleavage in vitro.
    Ben-Rafael Z; Kopf GS; Blasco L; Flickinger GL; Tureck RW; Strauss JF; Mastroianni L
    Fertil Steril; 1986 Jan; 45(1):51-7. PubMed ID: 3080346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles.
    Golan A; Herman A; Soffer Y; Bukovsky I; Caspi E; Ron-El R
    Hum Reprod; 1993 Sep; 8(9):1372-5. PubMed ID: 8253920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.